Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-193408
Filing Date
2006-09-19
Accepted
2006-09-19 17:23:01
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K d10ka.htm 10-K/A 1292400
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1793
3 CERTIFICATION OF CEO dex311.htm EX-31.1 8871
4 CERTIFICATION OF CFO dex312.htm EX-31.2 8875
5 CERTIFICATION FOR CEO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 3083
6 CERTIFICATION FOR CFO PURSUANT TO SECTION 1350 dex322.htm EX-32.2 3105
  Complete submission text file 0001193125-06-193408.txt   1319925
Mailing Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837
Business Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837 847-969-2700
Abraxis BioScience, Inc. (Filer) CIK: 0001141399 (see all company filings)

EIN.: 680389419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-33407 | Film No.: 061098706
SIC: 2834 Pharmaceutical Preparations